pre-IPO PHARMA

heartseed PRESS RELEASE ARCHIVE

Sep 11, 2023

Heartseed Announces the Presentation of HS-001, an Investigational Stem Cell-Derived Therapy for the Treatment of Advanced Heart Failure at the 71st Annual Meeting of the Japanese College of Cardiology


Sep 5, 2023

Heartseed Enters into induced Pluripotent Stem Cell Purification Patent License Agreement for Commercialization of Cell Therapy


May 25, 2023

Heartseed raises 2 billion JPY in series D funding to accelerate development of iPSC-derived stem cell therapy for heart failure


Jun 11, 2021

Heartseed Raises $37 Million in Series C Funding to Accelerate Development of iPSC-derived Stem Cell Therapy for Heart Failure


Nov 30, 2020

Heartseed Named "Healthcare Company of the Year 2020” by Healthcare Insights Magazine in the MedTech Category for Making a Crucial Impact in Healthcare



Sep 15, 2020

Mutsuki Takano Was Appointed as CFO at Heartseed


Mar 10, 2020

Heartseed and ITOCHU CHEMICAL FRONTIER Sign Capital Alliance Agreement to Explore iPSC and Cardiomyocyte Business Opportunities


Mar 10, 2020

Notice of Capital and Business Alliance Between Heartseed and MEDIPAL HOLDINGS


Nov 22, 2019

Heartseed Raises $26M in Series B Funding to Accelerate Development of iPSC-derived Regenerative Medicine for Heart Failure


Google Analytics Alternative